1 research outputs found
Pharmacological profile and clinical use of moexipril
- Author
- Bafour JA
- Brenner BM
- Brogden RN
- Chrysant SG
- Chrysant SG
- Cohn JN
- Dahlof B
- Frohlich ED
- Giatras I
- Grass GM
- Grohé C
- Hoefle ML
- Kamper AL
- Klutchko S
- Lewis EJ
- Lewis JE
- Lucas CD
- Maschio G
- Massarella
- Perico N
- Pfeffer MA
- Singhvi SM
- Siragy HM
- Song JC
- Stimpel M
- Stimpel M
- Stimpel M
- Stimpel M
- The ALLHAT officers and coordinators for the ALLHAT Collaborative Research Group
- The Seventh Report of the Joint National Committee on Prevention Evaluation, and Treatment of High Blood Pressure
- The SOLVD Investigators
- Todd PA
- Todd PA
- Todd PA
- Waldmeier F
- White WB
- Wong M
- •Advanced hypertensive heart disease in spontaneously hypertensive rats:
- •Antihypertensive effectiveness of a very low fixed-dose combination of moexipril and hydrochlorothiazide. j
- •as add-on therapy to hydrochlorothiazide in moderate to severe hypertension.
- •Comparison of moexipril a new ACE inhibitor, to verapamil-SR as add-on therapy to low dose hydrochlorothiazide in hypertensive patients.
- •Demasters K. Severe reversible azotemia from captopril therapy: report of three cases and review of the literature.
- •Diabetic nephropathy.
- •effectiveness of low-dose lisinopril—hydrochlorothiazide combination:
- •Kinins or nitric oxide
- •Kriegman A. Effects of benazepril and hydrochlorothiazide given alone and in low and high-dose combinations, on blood pressure in patients with hypertension.
- •Long term efficacy and safety of moexipril in the treatment of hypertension.
- •Moexipril in the treatment of mild to moderate essential hypertension: comparison with sustained release varapamil. j
- •Moexipril versus captopril in patients with mild to moderate hypertension.
- •Moexipril a new angiotensin converting enzyme (ACE) inhibitor:
- •Moexipril:
- •of the antihypertensive efficacy and tolerability of moexipril
- •Pharmacokinetics and ACE-inhibition of the new ACE-inhibitor moexipril:
- •system and vascular hypertrophy.
- •Todd M Stimpel M. Comparison of the efficacy of three dose levels of moexipril versus placebo as add-on therapy to hydrochlorothiazide in patients with moderate hypertension. j
- •treatment with moexipril plus HCTZ vs.
- •Tricenter assessment of the efficacy of the ACE inhibitor moexipril, by ambulatory blood pressure monitoring. j
- •Usefulness of moexipril and hydrochlorothiazide in moderately severe essential hypertension.
- •Weber MA.
- Publication venue
- 'Informa UK Limited'
- Publication date
- Field of study
No full text
